Obesity-associated sympathetic overactivity in children and adolescents: The role of catecholamine resistance in lipid metabolism

Journal of Pediatric Endocrinology and Metabolism

Volumn 29, Issue 2, 2016, Pages 113-125

  Qi, Zhengtang ^a,b   Ding, Shuzhe ^a,b  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b East China Normal University   (China)

Author keywords

catecholamine resistance; childhood obesity; insulin resistance; lipid metabolism; sympathetic activity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADRENALIN; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; FATTY ACID; GLUCOSE; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RENIN; RESISTIN;

ADIPOGENESIS; ADOLESCENT; ADRENERGIC SYSTEM; CATECHOLAMINE RESISTANCE; CHILD; CHILDHOOD OBESITY; EXERCISE; FATTY ACID TRANSPORT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MENTAL STRESS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SOCIAL STRESS; SYMPATHETIC NERVE; SYMPATHETIC OVERACTIVITY; OBESITY; PHYSIOLOGY;

ADOLESCENT; CATECHOLAMINES; CHILD; EXERCISE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; OBESITY; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 84958155530     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2015-0182     Document Type: Review

References (125)

1. Ziegler MG, Milic M, Sun P, Tang CM, Elayan H., et al. Endogenous epinephrine protects against obesity induced insulin resistance. Auton Neurosci 2011; 162: 32-4
2. Lee ZS, Critchley JA, Tomlinson B, Young RP, Thomas GN., et al. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 2001; 50: 135-43
3. Zouhal H, Lemoine-Morel S, Mathieu ME, Casazza GA, Jabbour G. Catecholamines and obesity: effects of exercise and training. Sports Med 2013; 43: 591-600
4. Collins S, Daniel KW, Petro AE, Surwit RS. Strain-specific response to beta 3-Adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology 1997; 138: 405-13
5. Lambert EA, Straznicky NE, Lambert GW. A sympathetic view of human obesity. Clin Auton Res 2013; 23: 9-14
6. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S., et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 2010; 285: 17271-6
7. Becton LJ, Shatat IF, Flynn JT. Hypertension and obesity: epidemiology, mechanisms and clinical approach. Indian J Pediatr 2012; 79: 1056-61
8. Bougneres P, Stunff CL, Pecqueur C, Pinglier E, Adnot P., et al. In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. J Clin Invest 1997; 99: 2568-73
9. Carel JC, Le Stunff C, Condamine L, Mallet E, Chaussain JL., et al. Resistance to the lipolytic action of epinephrine: a new feature of protein Gs deficiency. J Clin Endocrinol Metab 1999; 84: 4127-31
10. Wilson SM, Sato AF. Stress and paediatric obesity: what we know and where to go. Stress Health 2014; 30: 91-102
11. Holmes ME, Ekkekakis P, Eisenmann JC. The physical activity, stress and metabolic syndrome triangle: a guide to unfamiliar territory for the obesity researcher. Obes Rev 2010; 11: 492-507
12. Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnansky R., et al. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Ann N Y Acad Sci 2008; 1148: 232-7
13. Lin EJ, Sun M, Choi EY, Magee D, Stets CW., et al. Social overcrowding as a chronic stress model that increases adiposity in mice. Psychoneuroendocrino 2015; 51: 318-30
14. Prior LJ, Davern PJ, Burke SL, Lim K, Armitage JA., et al. Exposure to a high-fat diet during development alters leptin and ghrelin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2014; 63: 338-45
15. Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL., et al. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2010; 55: 862-U96
16. Lkhagvasuren B, Nakamura Y, Oka T, Sudo N, Nakamura K. Social defeat stress induces hyperthermia through activation of thermoregulatory sympathetic premotor neurons in the medullary raphe region. Eur J Neurosci 2011; 34: 1442-52
17. Perez-Tejada J, Arregi A, Gomez-Lazaro E, Vegas O, Azpiroz A., et al. Coping with chronic social stress in mice: hypothalamicpituitary-Adrenal/sympathetic-Adrenal-medullary axis activity, behavioral changes and effects of antalarmin treatment: implications for the study of stress-related psychopathologies. Neuroendocrinology 2013; 98: 73-88
18. Sloan EK, Capitanio JP, Tarara RP, Mendoza SP, Mason WA., et al. Social stress enhances sympathetic innervation of primate lymph nodes: mechanisms and implications for viral pathogenesis. J Neurosci 2007; 27: 8857-65
19. Seals DR, Bell C. Chronic sympathetic activation: consequence and cause of age-Associated obesity?. Diabetes 2004; 53: 276-84
20. Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr Hypertens Rev 2010; 6: 104-209
21. McDonald RB, Horwitz BA, Hamilton JS, Stern JS. Cold- and norepinephrine-induced thermogenesis in younger and older Fischer 344 rats. Am J Physiol 1988; 254(3 Pt 2): R457-62
22. McDonald RB, Herrmann S, Curry DL. Norepinephrine sensitivity of the endocrine pancreas in aging F344 rats. Aging (Milano) 1992; 4: 227-30
23. Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndrome-causes, consequences and therapeutic implications. Pharmacol Ther 2010; 126: 159-72
24. Lambert EA, Rice T, Eikelis N, Straznicky NE, Lambert GW., et al. Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss. Am J Hypertens 2014; 27: 1308-15
25. Chen W, Leo S, Weng C, Yang X, Wu Y., et al. Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension. Herz 2015; 40(Suppl 2): 190-6
26. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-80
27. Vaz M, Jennings G, Turner A, Cox H, Lambert G., et al. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96: 3423-9
28. Grassi G, Seravalle G, Brambilla G, Buzzi S, Volpe M., et al. Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea. J Hypertens 2014; 32: 383-8
29. Straznicky NE, Eikelis N, Lambert EA, Esler MD. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep 2008; 10: 440-7
30. Hering D, Kucharska W, Kara T, Somers VK, Parati G., et al. Effects of acute and long-term slow breathing exercise on muscle sympathetic nerve activity in untreated male patients with hypertension. J Hypertens 2013; 31: 739-46
31. Dulloo AG. Biomedicine. A sympathetic defense against obesity. Science 2002; 297: 780-1
32. Imai J, Katagiri H, Yamada T, Ishigaki Y, Ogihara T., et al. Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity 2006; 14: 1132-41
33. Xiang LS, Lu SL, Mittwede PN, Clemmer JS, Husband GW., et al. Beta(2)-Adrenoreceptor blockade improves early posttrauma hyperglycemia and pulmonary injury in obese rats. Am J Physiol-Heart C 2014; 307: H621-H7
34. Assadi F. The growing epidemic of hypertension among children and adolescents: a challenging road ahead. Pediatr Cardiol 2012; 33: 1013-20
35. Lee P, Kengne AP, Greenfield JR, Day RO, Chalmers J., et al. Metabolic sequelae of beta-blocker therapy: weighing in on the obesity epidemic?. Int J Obesity 2011; 35: 1395-403
36. Deedwania P. Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating beta-blockers. J Clin Hypertens 2011; 13: 52-9
37. Eyre EL, Duncan MJ, Birch SL, Fisher JP. The influence of age and weight status on cardiac autonomic control in healthy children: a review. Auton Neurosci-Basic 2014; 186: 8-21
38. Graziano PA, Calkins SD, Keane SP, O Brien M. Cardiovascular regulation profile predicts developmental trajectory of BMI and pediatric obesity. Obesity 2011; 19: 1818-25
39. Kaufman CL, Kaiser DR, Steinberger J, Kelly AS, Dengel DR. Relationships of cardiac autonomic function with metabolic abnormalities in childhood obesity. Obesity 2007; 15: 1164-71
40. de Faria AP, Modolo R, Fontana V, Moreno H. Adipokines: novel players in resistant hypertension. J Clin Hypertens (Greenwich) 2014; 16: 754-9
41. Ohashi K, Shibata R, Murohara T, Ouchi N. Role of anti-inflammatory adipokines in obesity-related diseases. Trends Endocrinol Metab 2014; 25: 348-55
42. Sayin O, Tokgoz Y, Arslan N. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease. J Pediatr Endocrinol Metab 2014; 27: 479-84
43. Nishimura R, Sano H, Matsudaira T, Miyashita Y, Morimoto A., et al. Childhood obesity and its relation to serum adiponectin and leptin: a report from a population-based study. Diabetes Res Clin Pract 2007; 76: 245-50
44. Simonds SE, Cowley MA, Enriori PJ. Leptin increasing sympathetic nerve outflow in obesity: a cure for obesity or a potential contributor to metabolic syndrome?. Adipocyte 2012; 1: 177-81
45. Morgan DA, Thedens DR, Weiss R, Rahmouni K. Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1730-6
46. Shi Z, Brooks VL. Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen. J Physiol 2015; 593: 1633-47
47. Ortega L, Riestra P, Navarro P, Gavela-Perez T, Soriano-Guillen L., et al. Resistin levels are related to fat mass, but not to body mass index in children. Peptides 2013; 49: 49-52
48. Chen XY, Zhang JH, Liu F, Liu HM, Song YY., et al. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children. J Pediatr Endocrinol Metab 2013; 26: 855-60
49. Kosari S, Rathner JA, Badoer E. Central resistin enhances renal sympathetic nerve activity via phosphatidylinositol 3-kinase but reduces the activity to brown adipose tissue via extracellular signal-regulated kinase 1/2. J Neuroendocrinol 2012; 24: 1432-9
50. Kosari S, Rathner JA, Chen F, Kosari S, Badoer E. Centrally administered resistin enhances sympathetic nerve activity to the hindlimb but attenuates the activity to brown adipose tissue. Endocrinology 2011; 152: 2626-33
51. Haider DG, Holzer G, Schaller G, Weghuber D, Widhalm K., et al. The adipokine visfatin is markedly elevated in obese children. J Pediatr Gastroenterol Nutr 2006; 43: 548-9
52. Ooi SQ, Chan RM, Poh LK, Loke KY, Heng CK., et al. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children. Pediatr Obes 2014; 9: 81-91
53. Martos-Moreno GA, Kratzsch J, Korner A, Barrios V, Hawkins F., et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism. Int J Obes (Lond) 2011; 35: 1355-62
54. Jamurtas A, Stavropoulos-Kalinoglou A, Koutsias S, Koutedakis Y, Fatouros I. Adiponectin, resistin and visfatin in childhood obesity and exercise. Pediatr Exerc Sci 2015 [Epub ahead of print].
55. Tanida M, Shen J, Horii Y, Matsuda M, Kihara S., et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med (Maywood) 2007; 232: 390-7
56. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-6
57. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K., et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 2006; 47: 1108-16
58. Surwit RS, Dixon TM, Petro AE, Daniel KW, Collins S. Diazoxide restores beta3-Adrenergic receptor function in diet-induced obesity and diabetes. Endocrinology 2000; 141: 3630-7
59. McAllan L, Skuse P, Cotter PD, O Connor P, Cryan JF., et al. Protein quality and the protein to carbohydrate ratio within a high fat diet influences energy balance and the gut microbiota In C57BL/6J mice. PLoS One 2014; 9: e88904
60. Aparecida de Franca S, Pavani Dos Santos M, Nunes Queiroz da Costa RV, Froelich M, Buzelle SL., et al. Low-protein, high-carbohydrate diet increases glucose uptake and fatty acid synthesis in brown adipose tissue of rats. Nutrition 2014; 30: 473-80
61. Yang L, Lu K, Wen XY, Liu H, Chen AP., et al. Jueming Prescription reduces body weight by increasing the mRNA expressions of beta3-Adrenergic receptor and uncoupling protein-2 in adipose tissue of diet-induced obese rats. Chin J Integr Med 2012; 18: 775-81
62. Bartolomucci A, La Corte G, Possenti R, Locatelli V, Rigamonti AE., et al. TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc Natl Acad Sci USA 2006; 103: 14584-9
63. Huang X, Charbeneau RA, Fu Y, Kaur K, Gerin I., et al. Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele. Diabetes 2008; 57: 77-85
64. Kaartinen JM, LaNoue KF, Martin LF, Vikman HL, Ohisalo JJ. Beta-Adrenergic responsiveness of adenylate cyclase in human adipocyte plasma membranes in obesity and after massive weight reduction. Metabolism 1995; 44: 1288-92
65. Wang Z, Li V, Chan GC, Phan T, Nudelman AS., et al. Adult type 3 adenylyl cyclase-deficient mice are obese. PLoS One 2009; 4: e6979
66. Nissim I, Horyn O, Daikhin Y, Chen P, Li C., et al. The molecular and metabolic influence of long term agmatine consumption. J Biol Chem 2014; 289: 9710-29
67. Illiano G, Naviglio S, Pagano M, Spina A, Chiosi E., et al. Leptin affects adenylate cyclase activity in H9c2 cardiac cell line: effects of short- and long-term exposure. Am J Hypertens 2002; 15(7 Pt 1): 638-43
68. Fruhbeck G, Gomez-Ambrosi J. Modulation of the leptin-induced white adipose tissue lipolysis by nitric oxide. Cell Signal 2001; 13: 827-33
69. Nakra N, Bhargava S, Dzuira J, Caprio S, Bazzy-Asaad A. Sleepdisordered breathing in children with metabolic syndrome: the role of leptin and sympathetic nervous system activity and the effect of continuous positive airway pressure. Pediatrics 2008; 122: e634-42
70. Adigun AA, Wrench N, Levin ED, Seidler FJ, Slotkin TA. Neonatal parathion exposure and interactions with a high-fat diet in adulthood: adenylyl cyclase-mediated cell signaling in heart, liver and cerebellum. Brain Res Bull 2010; 81: 605-12
71. London E, Rothenbuhler A, Lodish M, Gourgari E, Keil M., et al. Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications. J Clin Endocrinol Metab 2014; 99: E303-10
72. London E, Nesterova M, Sinaii N, Szarek E, Chanturiya T., et al. Differentially regulated protein kinase A (PKA) activity in adipose tissue and liver is associated with resistance to diet-induced obesity and glucose intolerance in mice that lack PKA regulatory subunit type IIalpha. Endocrinology 2014; 155: 3397-408
73. Czyzyk TA, Sikorski MA, Yang L, McKnight GS. Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of Agouti lethal yellow mice. Proc Natl Acad Sci USA 2008; 105: 276-81
74. Kou XH, Zhu MF, Chen D, Lu Y, Song HZ., et al. Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARalpha in rats fed a high-fat diet. Br J Pharmacol 2012; 165: 2692-706
75. Badin PM, Vila IK, Louche K, Mairal A, Marques M.A., et al. Highfat diet-mediated lipotoxicity and insulin resistance is related to impaired lipase expression in mouse skeletal muscle. Endocrinology 2013; 154: 1444-53
76. Gaidhu MP, Anthony NM, Patel P, Hawke TJ, Ceddia RB. Dysregulation of lipolysis and lipid metabolism in visceral and subcutaneous adipocytes by high-fat diet: role of ATGL, HSL, and AMPK. Am J Physiol Cell Physiol 2010; 298: C961-71
77. Khoo JC, Jarett L, Mayer SE, Steinberg D. Subcellular distribution of and epinephrine-induced changes in hormone-sensitive lipase, phosphorylase, and phosphorylase kinase in rat adipocytes. J Biol Chem 1972; 247: 4812-8
78. Prats C, Donsmark M, Qvortrup K, Londos C, Sztalryd C., et al. Decrease in intramuscular lipid droplets and translocation of HSL in response to muscle contraction and epinephrine. J Lipid Res 2006; 47: 2392-9
79. Lampidonis AD, Rogdakis E, Voutsinas GE, Stravopodis DJ. The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis. Gene 2011; 477: 1-11
80. Patel S, Yang W, Kozusko K, Saudek V, Savage DB. Perilipins 2 and 3 lack a carboxy-terminal domain present in perilipin 1 involved in sequestering ABHD5 and suppressing basal lipolysis. Proc Natl Acad Sci USA 2014; 111: 9163-8
81. Kern PA, Di Gregorio G, Lu T, Rassouli N, Ranganathan G. Perilipin expression in human adipose tissue is elevated with obesity. J Clin Endocrinol Metab 2004; 89: 1352-8
82. Rinnankoski-Tuikka R, Hulmi JJ, Torvinen S, Silvennoinen M, Lehti M., et al. Lipid droplet-Associated proteins in high-fat fed mice with the effects of voluntary running and diet change. Metabolism 2014; 63: 1031-40
83. Miyoshi H, Souza SC, Endo M, Sawada T, Perfield JW, 2nd., et al. Perilipin overexpression in mice protects against diet-induced obesity. J Lipid Res 2010; 51: 975-82
84. Abu-Elheiga L, Oh W, Kordari P, Wakil SJ. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc Natl Acad Sci USA 2003; 100: 10207-12
85. Abu-Elheiga L, Wu H, Gu Z, Bressler R, Wakil SJ. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions. J Biol Chem 2012; 287: 12578-88
86. Hattori A, Mawatari K, Tsuzuki S, Yoshioka E, Toda S., et al. Betaadrenergic-AMPK pathway phosphorylates acetyl-CoA carboxylase in a high-epinephrine rat model, SPORTS. Obesity (Silver Spring) 2010; 18: 48-54
87. Konstandi M, Shah YM, Matsubara T, Gonzalez FJ. Role of PPARalpha and HNF4alpha in stress-mediated alterations in lipid homeostasis. PLoS One 2013; 8: e70675
88. Herzig S, Long F, Jhala US, Hedrick S, Quinn R., et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001; 413: 179-83
89. Herzig S, Hedrick S, Morantte I, Koo SH, Galimi F., et al. CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-gamma. Nature 2003; 426: 190-3
90. Fujimori K, Yano M, Miyake H, Kimura H. Termination mechanism of CREB-dependent activation of COX-2 expression in early phase of adipogenesis. Mol Cell Endocrinol 2014; 384: 12-22
91. Bocarsly ME, Avena NM. A high-fat diet or galanin in the PVN decreases phosphorylation of CREB in the nucleus accumbens. Neuroscience 2013; 248C: 61-6
92. Morris KA, Gold PE. Epinephrine and glucose modulate trainingrelated CREB phosphorylation in old rats: relationships to agerelated memory impairments. Exp Gerontol 2013; 48: 115-27
93. Jocken JW, Roepstorff C, Goossens GH, Van der Baan P, Van Baak M., et al. Hormone-sensitive lipase serine phosphorylation and glycerol exchange across skeletal muscle in lean and obese subjects: effect of beta-Adrenergic stimulation. Diabetes 2008; 57: 1834-41
94. Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem 2012; 287: 11968-80
95. Jost P, Fasshauer M, Kahn CR, Benito M, Meyer M., et al. Atypical beta-Adrenergic effects on insulin signaling and action in beta(3)-Adrenoceptor-deficient brown adipocytes. Am J Physiol Endocrinol Metab 2002; 283: E146-53
96. Cahova M, Palenickova E, Papackova Z, Dankova H, Skop V., et al. Epinephrine-dependent control of glucose metabolism in white adipose tissue: the role of alpha- and beta-Adrenergic signalling. Exp Biol Med (Maywood) 2012; 237: 211-8
97. Hunzicker-Dunn ME, Lopez-Biladeau B, Law NC, Fiedler SE, Carr DW., et al. PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells. Proc Natl Acad Sci USA 2012; 109: E2979-88
98. Frier BC, Jacobs RL, Wright DC. Interactions between the consumption of a high-fat diet and fasting in the regulation of fatty acid oxidation enzyme gene expression: an evaluation of potential mechanisms. Am J Physiol Regul Integr Comp Physiol 2011; 300: R212-21
99. Cortes VA, Curtis DE, Sukumaran S, Shao X, Parameswara V., et al. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy. Cell Metab 2009; 9: 165-76
100. Wang F, Mullican SE, DiSpirito JR, Peed LC, Lazar M.A. Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARgamma. Proc Natl Acad Sci USA 2013; 110: 18656-61
101. Myers MG, Jr, Leibel RL, Seeley RJ, Schwartz MW. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010; 21: 643-51
102. Berbari NF, Pasek RC, Malarkey EB, Yazdi SM, McNair AD., et al. Leptin resistance is a secondary consequence of the obesity in ciliopathy mutant mice. Proc Natl Acad Sci USA 2013; 110: 7796-801
103. Van Greevenbroek MM, Ghosh S, Van der Kallen CJ, Brouwers MC, Schalkwijk CG., et al. Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance. J Clin Endocrinol Metab 2012; 97: 4742-52
104. Bessey PQ, Brooks DC, Black PR, Aoki TT, Wilmore DW. Epinephrine acutely mediates skeletal muscle insulin resistance. Surgery 1983; 94: 172-9
105. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 1980; 65: 717-21
106. Scherer T, O Hare J, Diggs-Andrews K, Schweiger M, Cheng B., et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 2011; 13: 183-94
107. Kawashita NH, Moura MA, Brito MN, Brito SM, Garofalo M.A., et al. Relative importance of sympathetic outflow and insulin in the reactivation of brown adipose tissue lipogenesis in rats adapted to a high-protein diet. Metabolism 2002; 51: 343-9
108. Marion V, Mockel A, De Melo C, Obringer C, Claussmann A., et al. BBS-induced ciliary defect enhances adipogenesis, causing paradoxical higher-insulin sensitivity, glucose usage, and decreased inflammatory response. Cell Metab 2012; 16: 363-77
109. Chutkow WA, Birkenfeld AL, Brown JD, Lee HY, Frederick DW., et al. Deletion of the alpha-Arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity. Diabetes 2010; 59: 1424-34
110. Stener-Victorin E, Jedel E, Janson PO, Sverrisdottir YB. Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. Am J Physiol Regul Integr Comp Physiol 2009; 297: R387-95
111. Rengo G, Leosco D, Zincarelli C, Marchese M, Corbi G., et al. Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. Am J Physiol Heart Circ Physiol 2010; 298: H2032-8
112. Groehs RV, Toschi-Dias E, Antunes-Correa LM, Trevizan PF, Rondon MU., et al. Exercise training prevents the deterioration in the arterial baroreflex control of sympathetic nerve activity in chronic heart failure patients. Am J Physiol-Heart C 2015; 308: H1096-H102
113. Chen T, Cai MX, Li YY, He ZX, Shi XC., et al. Aerobic exercise inhibits sympathetic nerve sprouting and restores beta-Adrenergic receptor balance in rats with myocardial infarction. PLoS One 2014; 9: e97810
114. Stephenson EJ, Lessard SJ, Rivas DA, Watt MJ, Yaspelkis BB, 3rd., et al. Exercise training enhances white adipose tissue metabolism in rats selectively bred for low- or highendurance running capacity. Am J Physiol Endocrinol Metab 2013; 305: E429-38
115. Petridou A, Tsalouhidou S, Tsalis G, Schulz T, Michna H., et al. Long-term exercise increases the DNA binding activity of peroxisome proliferator-Activated receptor gamma in rat adipose tissue. Metabolism 2007; 56: 1029-36
116. Takekoshi K, Fukuhara M, Quin Z, Nissato S, Isobe K., et al. Long-term exercise stimulates adenosine monophosphateactivated protein kinase activity and subunit expression in rat visceral adipose tissue and liver. Metabolism 2006; 55: 1122-8
117. Palacios OM, Carmona JJ, Michan S, Chen KY, Manabe Y., et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging (Albany NY) 2009; 1: 771-83
118. Marion-Latard F, De Glisezinski I, Crampes F, Berlan M, Galitzky J., et al. A single bout of exercise induces beta-Adrenergic desensitization in human adipose tissue. Am J Physiol Regul Integr Comp Physiol 2001; 280: R166-73
119. Stich V, Marion-Latard F, Hejnova J, Viguerie N, Lefort C., et al. Hypocaloric diet reduces exercise-induced alpha 2-Adrenergic antilipolytic effect and alpha 2-Adrenergic receptor mRNA levels in adipose tissue of obese women. J Clin Endocrinol Metab 2002; 87: 1274-81
120. Stich V, De Glisezinski I, Crampes F, Hejnova J, Cottet-Emard JM., et al. Activation of alpha(2)-Adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. Am J Physiol Regul Integr Comp Physiol 2000; 279: R499-504
121. Richterova B, Stich V, Moro C, Polak J, Klimcakova E., et al. Effect of endurance training on adrenergic control of lipolysis in adipose tissue of obese women. J Clin Endocrinol Metab 2004; 89: 1325-31
122. Morrison C. Interaction between exercise and leptin in the treatment of obesity. Diabetes 2008; 57: 534-5
123. Seo DI, So WY, Ha S, Yoo EJ, Kim D., et al. Effects of 12 weeks of combined exercise training on visfatin and metabolic syndrome factors in obese middle-Aged women. J Sports Sci Med 2011; 10: 222-6
124. Cassaglia PA, Hermes SM, Aicher SA, Brooks VL. Insulin acts in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats. J Physiol 2011; 589(Pt 7): 1643-62
125. Monahan KD, Wilson TE, Ray CA. Omega-3 fatty acid supplementation augments sympathetic nerve activity responses to physiological stressors in humans. Hypertension 2004; 44: 732-8